Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Iovance Biotherapeutics (2LB.F) Q4 2023 Earnings
2LB.F
28
Feb
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.42
-0.41
-0.4
-0.4
Details
Expected EPS
-0.39744654884999997
Actual EPS
-0.4151745
Surprise EPS
-0.02
Surprise Percent
+4.46%
Description
Iovance Biotherapeutics (2LB.F) has reported earnings of -0.4151745 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login